A Better Way to Manage Cardiovascular Function
About 75 million (29%) American adults have high blood pressure 1,2
Approximately 1 of 3 (36%) American adults have prehypertension—blood pressure that’s higher than normal3
Only about half (54%) of people with high blood pressure have their condition under control 1
High blood pressure costs the nation $46 billion each year. This total includes the cost of health care services, medications to treat high blood pressure, and missed days of work 3
Pressao medical was incorporated in Delaware in 2018, developing the next generation smart non-invasive wrist wearable neuromodulation device for the treatment of resistant & uncontrooled hypertension. The company has strong intellectual properties.
Shawn Moaddeb
Chairman of the Board
Founder & Chairman of Pressao Medical., a medical technology incubator. Shawn is an entrepreneur with a strong background in both start-up and large established organizations (Johnson & Johnson, St. Jude Medical).
Shawn has held various leadership positions; CEO, senior executive, and board member. Shawn has co-founded multiple medical device companies with several successful exists: EP Dynamics, Lavita Technologies, Renal Dynamics, Vessix Vascular, Ellipse Technologies, Savona Therapeutics, and Oncogenics Guidance Systems. Shawn is also chairman of the board at Anaxiom Corp, chairman of the board at Vascular Health, and CEO & chairman of the board at Allevion Therapeutics.
View Team